A bill to provide for a cost and affordability review of certain prescription drug products; to create the prescription drug pricing board and prescription drug affordability stakeholder council and to prescribe their powers and duties; to provide for the powers and duties of certain state governmental officers and entities; to establish upper payment limits for certain prescription drug products and provide remedies; and to provide for the promulgation of rules.
This legislative package (SB 3-5) establishes a board and council to review prescription drug costs in Michigan, set upper payment limits if necessary, and is funded by a dedicated state fund.
Introduced
by
Referred to the Committee on Finance, Insurance, and Consumer Protection
